| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Retinol-Binding Proteins, Plasma | 23 | 2020 | 94 | 5.380 |
Why?
|
| Insulin Resistance | 87 | 2024 | 3982 | 5.360 |
Why?
|
| Monosaccharide Transport Proteins | 66 | 2005 | 437 | 5.110 |
Why?
|
| Adipocytes | 44 | 2024 | 1199 | 4.130 |
Why?
|
| Glucose Transporter Type 4 | 60 | 2024 | 241 | 3.710 |
Why?
|
| Glucose | 84 | 2024 | 4352 | 3.580 |
Why?
|
| Adipose Tissue | 73 | 2022 | 3335 | 3.350 |
Why?
|
| Insulin | 107 | 2023 | 6610 | 3.260 |
Why?
|
| Fatty Acids | 23 | 2024 | 1812 | 3.090 |
Why?
|
| Muscle Proteins | 41 | 2005 | 1165 | 3.070 |
Why?
|
| Esters | 10 | 2022 | 212 | 2.650 |
Why?
|
| Leptin | 27 | 2024 | 1597 | 2.340 |
Why?
|
| AMP-Activated Protein Kinases | 16 | 2024 | 598 | 2.280 |
Why?
|
| Stearic Acids | 7 | 2024 | 56 | 2.130 |
Why?
|
| Hypothalamus | 15 | 2016 | 1004 | 2.110 |
Why?
|
| Obesity | 59 | 2024 | 13087 | 1.970 |
Why?
|
| Palmitic Acid | 6 | 2024 | 149 | 1.890 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 1 | 18 | 2015 | 97 | 1.880 |
Why?
|
| Muscle, Skeletal | 47 | 2024 | 4980 | 1.620 |
Why?
|
| Diabetes Mellitus, Type 2 | 38 | 2023 | 12252 | 1.410 |
Why?
|
| Muscles | 31 | 2007 | 1582 | 1.400 |
Why?
|
| Lipogenesis | 6 | 2017 | 216 | 1.240 |
Why?
|
| Protein Tyrosine Phosphatases | 11 | 2007 | 458 | 1.230 |
Why?
|
| Retinol-Binding Proteins | 6 | 2009 | 67 | 1.230 |
Why?
|
| Multienzyme Complexes | 8 | 2006 | 665 | 1.180 |
Why?
|
| Liver | 35 | 2021 | 7579 | 1.160 |
Why?
|
| Mice | 135 | 2024 | 82074 | 1.080 |
Why?
|
| Blood Glucose | 39 | 2021 | 6434 | 1.070 |
Why?
|
| Homeostasis | 25 | 2022 | 3348 | 1.040 |
Why?
|
| Animals | 194 | 2024 | 169408 | 1.020 |
Why?
|
| Glucose Intolerance | 12 | 2021 | 579 | 0.980 |
Why?
|
| Energy Metabolism | 22 | 2021 | 2905 | 0.980 |
Why?
|
| Hydroxy Acids | 2 | 2022 | 19 | 0.950 |
Why?
|
| Eating | 13 | 2018 | 1542 | 0.930 |
Why?
|
| Amino Acids, Branched-Chain | 2 | 2021 | 268 | 0.900 |
Why?
|
| Mice, Knockout | 47 | 2024 | 14485 | 0.890 |
Why?
|
| Enzyme Activation | 14 | 2024 | 3588 | 0.890 |
Why?
|
| Phosphatidylinositol 3-Kinases | 24 | 2012 | 2884 | 0.890 |
Why?
|
| Insulin-Secreting Cells | 2 | 2022 | 899 | 0.880 |
Why?
|
| Isoenzymes | 9 | 2009 | 1687 | 0.860 |
Why?
|
| Adipose Tissue, White | 6 | 2020 | 371 | 0.860 |
Why?
|
| Signal Transduction | 56 | 2021 | 23652 | 0.840 |
Why?
|
| Diabetes Mellitus, Type 1 | 9 | 2022 | 3447 | 0.810 |
Why?
|
| Receptor, Insulin | 20 | 2018 | 838 | 0.800 |
Why?
|
| Diabetes Mellitus, Experimental | 15 | 2019 | 1124 | 0.790 |
Why?
|
| Adenylate Kinase | 5 | 2013 | 102 | 0.780 |
Why?
|
| Subcutaneous Fat | 3 | 2018 | 403 | 0.770 |
Why?
|
| Mice, Inbred C57BL | 39 | 2024 | 22381 | 0.760 |
Why?
|
| Oxidation-Reduction | 5 | 2024 | 2226 | 0.760 |
Why?
|
| Prealbumin | 4 | 2014 | 259 | 0.740 |
Why?
|
| Adaptive Immunity | 2 | 2016 | 733 | 0.740 |
Why?
|
| Thiazolidinediones | 6 | 2020 | 461 | 0.710 |
Why?
|
| Acyltransferases | 1 | 2022 | 306 | 0.700 |
Why?
|
| Stearates | 1 | 2019 | 6 | 0.690 |
Why?
|
| Body Weight | 25 | 2017 | 4628 | 0.680 |
Why?
|
| Toll-Like Receptor 4 | 2 | 2020 | 587 | 0.630 |
Why?
|
| Glucose Tolerance Test | 18 | 2019 | 1183 | 0.620 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 4 | 2021 | 325 | 0.620 |
Why?
|
| Biological Transport | 25 | 2007 | 2085 | 0.620 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2020 | 348 | 0.620 |
Why?
|
| Dietary Fats | 12 | 2022 | 2003 | 0.610 |
Why?
|
| Adipose Tissue, Brown | 8 | 2018 | 776 | 0.600 |
Why?
|
| Receptors, G-Protein-Coupled | 4 | 2019 | 1248 | 0.590 |
Why?
|
| 3T3 Cells | 13 | 2017 | 1085 | 0.580 |
Why?
|
| Protein Kinase C | 7 | 2016 | 1207 | 0.560 |
Why?
|
| Lipid Metabolism | 11 | 2022 | 1904 | 0.550 |
Why?
|
| Adipogenesis | 3 | 2018 | 371 | 0.540 |
Why?
|
| PPAR gamma | 5 | 2020 | 487 | 0.530 |
Why?
|
| Paneth Cells | 1 | 2016 | 100 | 0.520 |
Why?
|
| Phosphorylation | 27 | 2020 | 8317 | 0.520 |
Why?
|
| Immunoassay | 2 | 2012 | 746 | 0.510 |
Why?
|
| Gene Expression Regulation, Enzymologic | 5 | 2008 | 1169 | 0.510 |
Why?
|
| Inflammasomes | 1 | 2020 | 540 | 0.500 |
Why?
|
| Mice, Obese | 8 | 2024 | 418 | 0.490 |
Why?
|
| Ventromedial Hypothalamic Nucleus | 2 | 2014 | 46 | 0.480 |
Why?
|
| Nicotinamide N-Methyltransferase | 1 | 2014 | 10 | 0.460 |
Why?
|
| Metabolomics | 2 | 2021 | 1675 | 0.460 |
Why?
|
| Neurons | 13 | 2018 | 9524 | 0.460 |
Why?
|
| Ribosomal Protein S6 Kinases, 70-kDa | 2 | 2012 | 103 | 0.460 |
Why?
|
| Deoxyglucose | 8 | 2017 | 333 | 0.460 |
Why?
|
| Gene Expression Regulation | 22 | 2021 | 11934 | 0.450 |
Why?
|
| Th1 Cells | 2 | 2016 | 1042 | 0.450 |
Why?
|
| Antigen-Presenting Cells | 2 | 2016 | 962 | 0.450 |
Why?
|
| Glycogen | 11 | 2007 | 252 | 0.430 |
Why?
|
| Immunity, Mucosal | 1 | 2016 | 498 | 0.420 |
Why?
|
| Diet | 7 | 2021 | 8090 | 0.410 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Kinase | 1 | 2012 | 30 | 0.410 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2014 | 461 | 0.390 |
Why?
|
| Glucose Transporter Type 1 | 10 | 2017 | 186 | 0.390 |
Why?
|
| Thinness | 4 | 2014 | 483 | 0.390 |
Why?
|
| Rats | 43 | 2021 | 23847 | 0.390 |
Why?
|
| Male | 122 | 2024 | 365249 | 0.390 |
Why?
|
| Lipids | 6 | 2022 | 3345 | 0.380 |
Why?
|
| Nuclear Proteins | 3 | 2017 | 5803 | 0.380 |
Why?
|
| Hormones | 3 | 2007 | 871 | 0.380 |
Why?
|
| Mice, Transgenic | 27 | 2017 | 9564 | 0.370 |
Why?
|
| Fatty Liver | 3 | 2016 | 810 | 0.370 |
Why?
|
| Gene Expression | 16 | 2017 | 7602 | 0.360 |
Why?
|
| Glycolysis | 6 | 2021 | 838 | 0.360 |
Why?
|
| Receptors, Adrenergic | 1 | 2011 | 155 | 0.360 |
Why?
|
| Hypoglycemia | 3 | 2016 | 895 | 0.360 |
Why?
|
| Proto-Oncogene Proteins | 10 | 2005 | 4528 | 0.360 |
Why?
|
| Animal Feed | 3 | 2008 | 105 | 0.360 |
Why?
|
| Diabetes Mellitus | 14 | 2012 | 5892 | 0.350 |
Why?
|
| Antigen Presentation | 1 | 2016 | 1252 | 0.350 |
Why?
|
| Lipolysis | 4 | 2020 | 211 | 0.350 |
Why?
|
| Cell Survival | 2 | 2019 | 5794 | 0.350 |
Why?
|
| Fasting | 12 | 2021 | 1610 | 0.350 |
Why?
|
| Cyclin-Dependent Kinase 5 | 1 | 2010 | 110 | 0.350 |
Why?
|
| Glucose Clamp Technique | 10 | 2016 | 263 | 0.340 |
Why?
|
| Fenretinide | 1 | 2009 | 9 | 0.340 |
Why?
|
| Membrane Transport Proteins | 2 | 2010 | 1039 | 0.340 |
Why?
|
| Serine | 3 | 2016 | 831 | 0.340 |
Why?
|
| Transcription Factors | 7 | 2017 | 12174 | 0.320 |
Why?
|
| Retinoids | 1 | 2009 | 99 | 0.320 |
Why?
|
| Macrophages | 7 | 2020 | 5800 | 0.320 |
Why?
|
| Models, Biological | 16 | 2020 | 9499 | 0.320 |
Why?
|
| Down-Regulation | 3 | 2014 | 2941 | 0.310 |
Why?
|
| Insulin Receptor Substrate Proteins | 10 | 2010 | 558 | 0.310 |
Why?
|
| Glycogen Synthase | 5 | 2005 | 62 | 0.310 |
Why?
|
| RNA, Messenger | 30 | 2018 | 12809 | 0.310 |
Why?
|
| 3T3-L1 Cells | 4 | 2024 | 208 | 0.300 |
Why?
|
| Hypoglycemic Agents | 5 | 2010 | 3110 | 0.300 |
Why?
|
| Pro-Opiomelanocortin | 3 | 2015 | 138 | 0.300 |
Why?
|
| Colitis | 1 | 2016 | 1244 | 0.290 |
Why?
|
| Proto-Oncogene Proteins c-akt | 13 | 2012 | 2460 | 0.290 |
Why?
|
| Receptors, Androgen | 1 | 2014 | 1091 | 0.290 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 4 | 1997 | 434 | 0.290 |
Why?
|
| Transgenes | 3 | 2013 | 1016 | 0.270 |
Why?
|
| Mice, Inbred NOD | 2 | 2022 | 1839 | 0.270 |
Why?
|
| Triglycerides | 6 | 2022 | 2464 | 0.270 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 6 | 2002 | 492 | 0.270 |
Why?
|
| Sirtuin 1 | 3 | 2014 | 247 | 0.270 |
Why?
|
| Humans | 114 | 2024 | 768887 | 0.260 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 2016 | 4413 | 0.260 |
Why?
|
| Mitochondrial Proteins | 4 | 2011 | 980 | 0.250 |
Why?
|
| Genes, ras | 3 | 1998 | 665 | 0.250 |
Why?
|
| Blotting, Western | 13 | 2016 | 5035 | 0.250 |
Why?
|
| Vitamin A | 5 | 2014 | 611 | 0.250 |
Why?
|
| Mass Spectrometry | 5 | 2018 | 2204 | 0.250 |
Why?
|
| Cells, Cultured | 18 | 2020 | 19023 | 0.250 |
Why?
|
| Cardiomegaly | 3 | 2015 | 591 | 0.250 |
Why?
|
| Lymphocyte Activation | 1 | 2016 | 5505 | 0.240 |
Why?
|
| Inflammation | 8 | 2024 | 10869 | 0.240 |
Why?
|
| Membrane Proteins | 5 | 2016 | 7885 | 0.240 |
Why?
|
| Carrier Proteins | 8 | 2021 | 4940 | 0.240 |
Why?
|
| Cell Communication | 2 | 2012 | 1660 | 0.230 |
Why?
|
| Hunger | 1 | 2006 | 207 | 0.230 |
Why?
|
| Immunity, Innate | 1 | 2016 | 3080 | 0.230 |
Why?
|
| Glucose Metabolism Disorders | 2 | 2018 | 52 | 0.220 |
Why?
|
| Protein Kinases | 3 | 2006 | 1611 | 0.220 |
Why?
|
| Islets of Langerhans | 6 | 2019 | 1351 | 0.220 |
Why?
|
| Aminopeptidases | 1 | 2004 | 114 | 0.220 |
Why?
|
| Rats, Sprague-Dawley | 12 | 2016 | 8200 | 0.220 |
Why?
|
| Interferon Regulatory Factor-3 | 1 | 2024 | 146 | 0.210 |
Why?
|
| Stereoisomerism | 2 | 2021 | 612 | 0.210 |
Why?
|
| Feeding Behavior | 2 | 2006 | 3206 | 0.210 |
Why?
|
| Female | 75 | 2024 | 397464 | 0.210 |
Why?
|
| Phosphoproteins | 10 | 2008 | 2452 | 0.210 |
Why?
|
| Esterification | 1 | 2022 | 39 | 0.210 |
Why?
|
| Insulin Antagonists | 1 | 2002 | 17 | 0.200 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 3 | 2014 | 440 | 0.200 |
Why?
|
| Rats, Inbred Strains | 12 | 1991 | 2087 | 0.200 |
Why?
|
| Intra-Abdominal Fat | 1 | 2007 | 624 | 0.200 |
Why?
|
| src Homology Domains | 2 | 2000 | 361 | 0.200 |
Why?
|
| Glucagon | 4 | 2019 | 534 | 0.190 |
Why?
|
| Diglycerides | 1 | 2022 | 176 | 0.190 |
Why?
|
| Chromans | 1 | 2002 | 116 | 0.190 |
Why?
|
| Molecular Structure | 3 | 2021 | 1885 | 0.190 |
Why?
|
| Promoter Regions, Genetic | 6 | 2013 | 5801 | 0.190 |
Why?
|
| Ribosomal Protein S6 Kinases | 4 | 2010 | 203 | 0.190 |
Why?
|
| Organ Specificity | 11 | 2013 | 1970 | 0.190 |
Why?
|
| Potassium Channels | 2 | 2002 | 538 | 0.190 |
Why?
|
| Tissue Distribution | 4 | 2014 | 2299 | 0.190 |
Why?
|
| Growth Differentiation Factor 3 | 1 | 2020 | 11 | 0.180 |
Why?
|
| Physical Conditioning, Animal | 3 | 2018 | 363 | 0.180 |
Why?
|
| Molecular Sequence Data | 15 | 2016 | 17629 | 0.180 |
Why?
|
| Ion Channels | 4 | 2011 | 1044 | 0.180 |
Why?
|
| Arabidopsis Proteins | 1 | 2002 | 264 | 0.180 |
Why?
|
| Phosphoprotein Phosphatases | 4 | 2005 | 329 | 0.180 |
Why?
|
| Tyrosine | 8 | 2005 | 1427 | 0.180 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 1 | 2022 | 362 | 0.170 |
Why?
|
| Denervation | 1 | 2021 | 265 | 0.170 |
Why?
|
| Coculture Techniques | 2 | 2016 | 1342 | 0.170 |
Why?
|
| Adenoviridae | 7 | 2005 | 1095 | 0.170 |
Why?
|
| Kinetics | 12 | 2009 | 6334 | 0.170 |
Why?
|
| Plant Proteins | 1 | 2002 | 376 | 0.170 |
Why?
|
| Metabolome | 2 | 2021 | 1009 | 0.170 |
Why?
|
| Fatty Acid-Binding Proteins | 3 | 2013 | 294 | 0.170 |
Why?
|
| Muscle Fibers, Skeletal | 5 | 2024 | 553 | 0.170 |
Why?
|
| Joint Prosthesis | 2 | 2016 | 251 | 0.170 |
Why?
|
| Oxygen | 4 | 2010 | 4273 | 0.160 |
Why?
|
| Blood Pressure | 2 | 2015 | 8541 | 0.160 |
Why?
|
| Dietary Sucrose | 1 | 2021 | 243 | 0.160 |
Why?
|
| Nerve Tissue Proteins | 1 | 2012 | 4415 | 0.160 |
Why?
|
| Protein Isoforms | 4 | 2012 | 1714 | 0.160 |
Why?
|
| Glucosamine | 1 | 1999 | 128 | 0.160 |
Why?
|
| Multifactorial Inheritance | 1 | 2007 | 1423 | 0.160 |
Why?
|
| HLA Antigens | 1 | 2004 | 1336 | 0.150 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 8 | 2017 | 2892 | 0.150 |
Why?
|
| Body Mass Index | 9 | 2021 | 13054 | 0.150 |
Why?
|
| Body Composition | 10 | 2017 | 2461 | 0.150 |
Why?
|
| Integrases | 2 | 2013 | 520 | 0.150 |
Why?
|
| Palmitic Acids | 1 | 2017 | 53 | 0.150 |
Why?
|
| Adiposity | 4 | 2018 | 1895 | 0.150 |
Why?
|
| Acetyl-CoA Carboxylase | 4 | 2007 | 72 | 0.140 |
Why?
|
| Recombinant Proteins | 6 | 2014 | 6512 | 0.140 |
Why?
|
| Cell Membrane | 11 | 2016 | 3659 | 0.140 |
Why?
|
| Feces | 1 | 2024 | 1511 | 0.140 |
Why?
|
| Bone Marrow Cells | 2 | 2016 | 2414 | 0.140 |
Why?
|
| Phlorhizin | 3 | 2017 | 37 | 0.140 |
Why?
|
| Genes, Dominant | 3 | 2010 | 856 | 0.140 |
Why?
|
| Tumor Necrosis Factor-alpha | 3 | 2020 | 4356 | 0.140 |
Why?
|
| Myostatin | 1 | 2018 | 129 | 0.140 |
Why?
|
| Overweight | 1 | 2008 | 2445 | 0.140 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 2 | 3 | 2015 | 50 | 0.140 |
Why?
|
| Proteins | 5 | 2002 | 6011 | 0.140 |
Why?
|
| Quadriceps Muscle | 1 | 2018 | 157 | 0.140 |
Why?
|
| Interferon Regulatory Factors | 1 | 2018 | 271 | 0.140 |
Why?
|
| Fatty Acids, Nonesterified | 3 | 2001 | 394 | 0.140 |
Why?
|
| Carboxylesterase | 1 | 2016 | 31 | 0.140 |
Why?
|
| Biological Transport, Active | 4 | 2000 | 323 | 0.140 |
Why?
|
| Methylglucosides | 4 | 1990 | 35 | 0.130 |
Why?
|
| Corticotropin-Releasing Hormone | 1 | 2018 | 360 | 0.130 |
Why?
|
| Protein Phosphatase 1 | 4 | 2005 | 135 | 0.130 |
Why?
|
| Cyclic AMP | 2 | 2019 | 1470 | 0.130 |
Why?
|
| Sulfonylurea Compounds | 2 | 1995 | 220 | 0.130 |
Why?
|
| Chromatography, Liquid | 2 | 2018 | 997 | 0.130 |
Why?
|
| Regeneration | 1 | 2024 | 1524 | 0.130 |
Why?
|
| Brain | 8 | 2016 | 27476 | 0.130 |
Why?
|
| p21-Activated Kinases | 1 | 2016 | 127 | 0.130 |
Why?
|
| Cytochalasin B | 6 | 2017 | 74 | 0.120 |
Why?
|
| Dextran Sulfate | 1 | 2016 | 258 | 0.120 |
Why?
|
| Gliclazide | 1 | 1995 | 3 | 0.120 |
Why?
|
| Energy Intake | 5 | 2011 | 2146 | 0.120 |
Why?
|
| Hydrolases | 1 | 2016 | 146 | 0.120 |
Why?
|
| Hormones, Ectopic | 2 | 2005 | 37 | 0.120 |
Why?
|
| ras Proteins | 3 | 1999 | 1058 | 0.120 |
Why?
|
| Hyperinsulinism | 7 | 2008 | 402 | 0.120 |
Why?
|
| Stress, Physiological | 1 | 2022 | 1410 | 0.120 |
Why?
|
| Hypertension | 1 | 2015 | 8615 | 0.120 |
Why?
|
| Angiotensin II | 2 | 2015 | 844 | 0.120 |
Why?
|
| Interleukin-1beta | 1 | 2020 | 1027 | 0.120 |
Why?
|
| Steroidogenic Factor 1 | 1 | 2014 | 45 | 0.120 |
Why?
|
| Myocardial Contraction | 1 | 1999 | 1526 | 0.120 |
Why?
|
| Thiazoles | 1 | 2002 | 1542 | 0.120 |
Why?
|
| Oxidoreductases Acting on CH-NH Group Donors | 1 | 2014 | 62 | 0.110 |
Why?
|
| Ornithine Decarboxylase | 1 | 2014 | 63 | 0.110 |
Why?
|
| rab GTP-Binding Proteins | 1 | 2016 | 247 | 0.110 |
Why?
|
| Spermine | 1 | 2014 | 70 | 0.110 |
Why?
|
| Weight-Bearing | 1 | 2017 | 534 | 0.110 |
Why?
|
| Base Sequence | 9 | 2008 | 12430 | 0.110 |
Why?
|
| Middle Aged | 31 | 2021 | 223740 | 0.110 |
Why?
|
| Thyrotropin | 2 | 1988 | 834 | 0.110 |
Why?
|
| COS Cells | 4 | 2002 | 1135 | 0.110 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2018 | 800 | 0.110 |
Why?
|
| Immune System | 1 | 2019 | 800 | 0.110 |
Why?
|
| HEK293 Cells | 3 | 2018 | 4291 | 0.110 |
Why?
|
| Peptide Hormones | 1 | 2014 | 132 | 0.110 |
Why?
|
| Mannose-Binding Lectins | 1 | 2014 | 101 | 0.110 |
Why?
|
| Gene Deletion | 4 | 2010 | 2674 | 0.110 |
Why?
|
| Glycogen Synthase Kinase 3 | 3 | 2005 | 414 | 0.110 |
Why?
|
| Adult | 34 | 2021 | 223818 | 0.110 |
Why?
|
| Atherosclerosis | 1 | 2009 | 3431 | 0.110 |
Why?
|
| Immunoblotting | 8 | 2017 | 1647 | 0.110 |
Why?
|
| Gastric Bypass | 1 | 2021 | 824 | 0.110 |
Why?
|
| Liver Glycogen | 3 | 2005 | 36 | 0.110 |
Why?
|
| Reference Values | 8 | 2008 | 4941 | 0.100 |
Why?
|
| Acetyltransferases | 1 | 2014 | 231 | 0.100 |
Why?
|
| S-Adenosylmethionine | 1 | 2014 | 219 | 0.100 |
Why?
|
| Naphthalimides | 1 | 2012 | 22 | 0.100 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2012 | 3814 | 0.100 |
Why?
|
| 3-O-Methylglucose | 5 | 1998 | 37 | 0.100 |
Why?
|
| Cell Size | 5 | 2017 | 626 | 0.100 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2022 | 2960 | 0.100 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2015 | 706 | 0.100 |
Why?
|
| Cell Line | 10 | 2016 | 15603 | 0.100 |
Why?
|
| Agouti-Related Protein | 1 | 2012 | 95 | 0.100 |
Why?
|
| Niacinamide | 1 | 2014 | 418 | 0.100 |
Why?
|
| Antimetabolites | 1 | 2012 | 129 | 0.100 |
Why?
|
| Myocardium | 4 | 2017 | 4790 | 0.100 |
Why?
|
| Glucagon-Like Peptide 1 | 1 | 2014 | 374 | 0.100 |
Why?
|
| Phosphoenolpyruvate Carboxykinase (GTP) | 2 | 2005 | 40 | 0.100 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2016 | 582 | 0.100 |
Why?
|
| Hexokinase | 2 | 2005 | 124 | 0.100 |
Why?
|
| Prostatic Neoplasms | 2 | 2014 | 11229 | 0.090 |
Why?
|
| Proteome | 1 | 2021 | 1891 | 0.090 |
Why?
|
| Obesity, Morbid | 2 | 2020 | 1300 | 0.090 |
Why?
|
| Rats, Zucker | 3 | 2000 | 131 | 0.090 |
Why?
|
| Time Factors | 14 | 2021 | 40266 | 0.090 |
Why?
|
| Cell Proliferation | 3 | 2017 | 10486 | 0.090 |
Why?
|
| Adrenergic Antagonists | 1 | 2011 | 26 | 0.090 |
Why?
|
| Blood Proteins | 1 | 1996 | 1191 | 0.090 |
Why?
|
| Crosses, Genetic | 4 | 2013 | 752 | 0.090 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 2 | 2010 | 224 | 0.090 |
Why?
|
| Blotting, Northern | 5 | 2000 | 1553 | 0.090 |
Why?
|
| Vasodilation | 1 | 2015 | 967 | 0.090 |
Why?
|
| Taxoids | 1 | 2014 | 668 | 0.090 |
Why?
|
| Protein Kinase C-epsilon | 2 | 2003 | 43 | 0.090 |
Why?
|
| Glucose-6-Phosphate | 2 | 2005 | 29 | 0.090 |
Why?
|
| Lectins, C-Type | 1 | 2014 | 593 | 0.090 |
Why?
|
| Prosthesis-Related Infections | 1 | 2016 | 497 | 0.090 |
Why?
|
| Receptors, Cell Surface | 2 | 2014 | 2820 | 0.090 |
Why?
|
| Cell Differentiation | 6 | 2016 | 11684 | 0.090 |
Why?
|
| Exercise | 4 | 2006 | 5953 | 0.090 |
Why?
|
| Hepatocytes | 4 | 2021 | 1246 | 0.090 |
Why?
|
| Adiponectin | 3 | 2013 | 1117 | 0.090 |
Why?
|
| Drug Administration Schedule | 2 | 2009 | 4862 | 0.090 |
Why?
|
| NAD | 1 | 2014 | 618 | 0.080 |
Why?
|
| DNA-Binding Proteins | 6 | 2008 | 9618 | 0.080 |
Why?
|
| Monocarboxylic Acid Transporters | 1 | 2010 | 81 | 0.080 |
Why?
|
| Spleen | 1 | 2016 | 2294 | 0.080 |
Why?
|
| Microsomes | 4 | 1997 | 252 | 0.080 |
Why?
|
| Food | 3 | 1990 | 768 | 0.080 |
Why?
|
| Phosphatidylcholines | 1 | 1991 | 406 | 0.080 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 2 | 1997 | 1769 | 0.080 |
Why?
|
| Amino Acid Sequence | 9 | 2016 | 13427 | 0.080 |
Why?
|
| Gene Knockdown Techniques | 1 | 2014 | 1608 | 0.080 |
Why?
|
| Sympathetic Nervous System | 2 | 2003 | 521 | 0.080 |
Why?
|
| Mice, Mutant Strains | 4 | 2012 | 1755 | 0.080 |
Why?
|
| Patch-Clamp Techniques | 1 | 2012 | 927 | 0.080 |
Why?
|
| Genetic Vectors | 3 | 2001 | 3414 | 0.080 |
Why?
|
| Podocytes | 1 | 2013 | 403 | 0.080 |
Why?
|
| Calorimetry, Indirect | 1 | 2009 | 176 | 0.080 |
Why?
|
| Streptozocin | 3 | 1997 | 190 | 0.080 |
Why?
|
| Cromolyn Sodium | 1 | 2009 | 78 | 0.080 |
Why?
|
| Heterozygote | 1 | 2016 | 2798 | 0.080 |
Why?
|
| Macrophage Activation | 1 | 2012 | 556 | 0.080 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2011 | 501 | 0.080 |
Why?
|
| Symporters | 2 | 2003 | 363 | 0.080 |
Why?
|
| Protein Subunits | 1 | 2012 | 943 | 0.080 |
Why?
|
| Enzyme Inhibitors | 6 | 2011 | 3724 | 0.080 |
Why?
|
| Dietary Supplements | 1 | 2021 | 3442 | 0.080 |
Why?
|
| Recombination, Genetic | 1 | 2013 | 1526 | 0.070 |
Why?
|
| Phosphorus Radioisotopes | 1 | 1987 | 100 | 0.070 |
Why?
|
| Dietary Carbohydrates | 1 | 1993 | 896 | 0.070 |
Why?
|
| Brain Chemistry | 2 | 2006 | 962 | 0.070 |
Why?
|
| Neuronal Plasticity | 1 | 2016 | 1449 | 0.070 |
Why?
|
| Methylglycosides | 1 | 1987 | 10 | 0.070 |
Why?
|
| Estrogens | 1 | 2014 | 1537 | 0.070 |
Why?
|
| Receptors, Leptin | 2 | 2011 | 352 | 0.070 |
Why?
|
| Subcellular Fractions | 2 | 2004 | 527 | 0.070 |
Why?
|
| Resistin | 2 | 2005 | 172 | 0.070 |
Why?
|
| Alkyl and Aryl Transferases | 2 | 1999 | 87 | 0.070 |
Why?
|
| Hemangioma, Cavernous | 1 | 2008 | 107 | 0.070 |
Why?
|
| Aorta | 1 | 2015 | 2046 | 0.070 |
Why?
|
| DNA | 5 | 1997 | 7214 | 0.070 |
Why?
|
| Ketosis | 1 | 2007 | 46 | 0.070 |
Why?
|
| Ketone Bodies | 1 | 2007 | 76 | 0.070 |
Why?
|
| Recombinant Fusion Proteins | 6 | 2013 | 3744 | 0.070 |
Why?
|
| Proto-Oncogenes | 1 | 2008 | 322 | 0.070 |
Why?
|
| Genotype | 3 | 2017 | 13048 | 0.070 |
Why?
|
| Benzimidazoles | 1 | 2012 | 864 | 0.070 |
Why?
|
| Aminoimidazole Carboxamide | 1 | 2006 | 85 | 0.070 |
Why?
|
| Transfection | 7 | 2007 | 5763 | 0.070 |
Why?
|
| Ribonucleotides | 1 | 2006 | 114 | 0.070 |
Why?
|
| Cathepsins | 1 | 2007 | 242 | 0.070 |
Why?
|
| TOR Serine-Threonine Kinases | 2 | 2006 | 2063 | 0.070 |
Why?
|
| Intestine, Small | 1 | 1992 | 1218 | 0.070 |
Why?
|
| Acute-Phase Proteins | 1 | 2007 | 252 | 0.070 |
Why?
|
| Glycogen Phosphorylase | 1 | 2005 | 15 | 0.070 |
Why?
|
| Gluconeogenesis | 1 | 2007 | 185 | 0.060 |
Why?
|
| Cytokines | 6 | 2012 | 7453 | 0.060 |
Why?
|
| Hypertrophy | 2 | 2018 | 562 | 0.060 |
Why?
|
| Injections, Intraperitoneal | 1 | 2006 | 413 | 0.060 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 2 | 2002 | 1731 | 0.060 |
Why?
|
| Drug Resistance | 1 | 2012 | 1600 | 0.060 |
Why?
|
| Phosphotyrosine | 2 | 2004 | 458 | 0.060 |
Why?
|
| Glycogen Synthase Kinases | 2 | 2002 | 40 | 0.060 |
Why?
|
| Antibodies, Anti-Idiotypic | 1 | 1987 | 355 | 0.060 |
Why?
|
| Injections, Intravenous | 1 | 2008 | 1379 | 0.060 |
Why?
|
| Apyrase | 1 | 2008 | 376 | 0.060 |
Why?
|
| DNA Primers | 5 | 2004 | 2827 | 0.060 |
Why?
|
| Transcription, Genetic | 4 | 2008 | 7609 | 0.060 |
Why?
|
| Viral Proteins | 1 | 2013 | 1802 | 0.060 |
Why?
|
| Glycerol | 2 | 2007 | 274 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2009 | 725 | 0.060 |
Why?
|
| Hypertriglyceridemia | 1 | 2008 | 293 | 0.060 |
Why?
|
| Neurosecretory Systems | 1 | 2006 | 223 | 0.060 |
Why?
|
| Barium Compounds | 1 | 2024 | 19 | 0.060 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2002 | 1658 | 0.060 |
Why?
|
| Gene Targeting | 2 | 2001 | 841 | 0.060 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2012 | 1966 | 0.060 |
Why?
|
| Phosphotransferases | 2 | 2004 | 302 | 0.060 |
Why?
|
| Protein Structure, Tertiary | 1 | 2012 | 3775 | 0.060 |
Why?
|
| Cysteine Endopeptidases | 1 | 2007 | 542 | 0.060 |
Why?
|
| Waist Circumference | 1 | 2008 | 935 | 0.060 |
Why?
|
| Receptors, Melanocortin | 1 | 2004 | 23 | 0.060 |
Why?
|
| Cystinyl Aminopeptidase | 1 | 2004 | 2 | 0.060 |
Why?
|
| Fructose | 2 | 2017 | 284 | 0.060 |
Why?
|
| Fishes | 1 | 1987 | 606 | 0.060 |
Why?
|
| Diet, Carbohydrate-Restricted | 1 | 2007 | 263 | 0.060 |
Why?
|
| R-SNARE Proteins | 1 | 2004 | 73 | 0.060 |
Why?
|
| Cell Compartmentation | 2 | 1997 | 383 | 0.060 |
Why?
|
| Lipoproteins, VLDL | 1 | 2004 | 201 | 0.060 |
Why?
|
| Mitochondria | 3 | 2018 | 3683 | 0.060 |
Why?
|
| Phosphatidylinositol Phosphates | 1 | 2004 | 201 | 0.050 |
Why?
|
| Cell Fractionation | 2 | 1996 | 247 | 0.050 |
Why?
|
| Cytosol | 2 | 1997 | 886 | 0.050 |
Why?
|
| Precipitin Tests | 1 | 2004 | 816 | 0.050 |
Why?
|
| Protein Kinase C-alpha | 1 | 2003 | 113 | 0.050 |
Why?
|
| Oncogene Proteins | 1 | 2007 | 718 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 3 | 2001 | 478 | 0.050 |
Why?
|
| Nurses | 1 | 2013 | 2501 | 0.050 |
Why?
|
| STAT1 Transcription Factor | 2 | 2004 | 344 | 0.050 |
Why?
|
| Mammary Glands, Animal | 1 | 2004 | 273 | 0.050 |
Why?
|
| Trans-Activators | 2 | 2004 | 2858 | 0.050 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2005 | 414 | 0.050 |
Why?
|
| Lactic Acid | 3 | 2007 | 1140 | 0.050 |
Why?
|
| Hypothyroidism | 1 | 1988 | 668 | 0.050 |
Why?
|
| Actins | 5 | 1998 | 2065 | 0.050 |
Why?
|
| Cell Division | 4 | 2001 | 4478 | 0.050 |
Why?
|
| Endoplasmic Reticulum | 1 | 2008 | 1133 | 0.050 |
Why?
|
| Disease Models, Animal | 5 | 2013 | 18366 | 0.050 |
Why?
|
| Carbon | 1 | 2006 | 672 | 0.050 |
Why?
|
| Phentolamine | 1 | 2002 | 102 | 0.050 |
Why?
|
| Lactates | 2 | 2001 | 401 | 0.050 |
Why?
|
| Feedback | 1 | 2006 | 799 | 0.050 |
Why?
|
| Arthroplasty, Replacement, Hip | 2 | 2005 | 1421 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinases | 3 | 2004 | 1246 | 0.050 |
Why?
|
| Radioimmunoassay | 2 | 1996 | 862 | 0.050 |
Why?
|
| Androstadienes | 2 | 2001 | 348 | 0.050 |
Why?
|
| Hyperplasia | 2 | 2017 | 1154 | 0.050 |
Why?
|
| Dipeptidases | 1 | 2021 | 38 | 0.050 |
Why?
|
| Mast Cells | 1 | 2009 | 1406 | 0.050 |
Why?
|
| Reproducibility of Results | 3 | 2012 | 20244 | 0.050 |
Why?
|
| Chlorides | 1 | 2024 | 666 | 0.050 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 2 | 1 | 2021 | 68 | 0.050 |
Why?
|
| Aurothioglucose | 2 | 2002 | 11 | 0.050 |
Why?
|
| T-Lymphocytes | 1 | 2019 | 10276 | 0.050 |
Why?
|
| Isoproterenol | 1 | 2002 | 398 | 0.050 |
Why?
|
| Adrenergic alpha-Antagonists | 1 | 2002 | 173 | 0.050 |
Why?
|
| Atrial Natriuretic Factor | 2 | 1999 | 350 | 0.050 |
Why?
|
| Physical Education and Training | 1 | 2002 | 102 | 0.050 |
Why?
|
| DNA Replication | 2 | 1999 | 1428 | 0.050 |
Why?
|
| Aged | 15 | 2019 | 171790 | 0.050 |
Why?
|
| Cross-Sectional Studies | 6 | 2012 | 26384 | 0.050 |
Why?
|
| Protein Transport | 3 | 2016 | 1956 | 0.050 |
Why?
|
| Hep G2 Cells | 2 | 2013 | 378 | 0.050 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 1 | 1 | 2021 | 126 | 0.050 |
Why?
|
| Computational Biology | 1 | 2013 | 3562 | 0.050 |
Why?
|
| Genistein | 1 | 2001 | 87 | 0.050 |
Why?
|
| Arthroplasty, Replacement | 1 | 2004 | 311 | 0.040 |
Why?
|
| Antibodies, Monoclonal | 2 | 1988 | 9264 | 0.040 |
Why?
|
| Portal Vein | 1 | 2003 | 435 | 0.040 |
Why?
|
| Polycystic Ovary Syndrome | 1 | 2004 | 383 | 0.040 |
Why?
|
| Adrenergic beta-Agonists | 1 | 2002 | 347 | 0.040 |
Why?
|
| Cricetinae | 4 | 2011 | 2423 | 0.040 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2002 | 481 | 0.040 |
Why?
|
| STAT3 Transcription Factor | 2 | 2004 | 875 | 0.040 |
Why?
|
| Injections, Intraventricular | 1 | 2000 | 227 | 0.040 |
Why?
|
| Ankle Joint | 1 | 2004 | 452 | 0.040 |
Why?
|
| Cohort Studies | 3 | 2013 | 41800 | 0.040 |
Why?
|
| Health Status | 1 | 2013 | 4095 | 0.040 |
Why?
|
| Physical Exertion | 2 | 1993 | 668 | 0.040 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2005 | 3811 | 0.040 |
Why?
|
| Mice, Inbred Strains | 2 | 2007 | 1769 | 0.040 |
Why?
|
| Genetic Variation | 3 | 2007 | 6610 | 0.040 |
Why?
|
| Transforming Growth Factor beta | 2 | 2018 | 2004 | 0.040 |
Why?
|
| beta-Galactosidase | 2 | 2000 | 575 | 0.040 |
Why?
|
| Vaginitis | 1 | 1999 | 50 | 0.040 |
Why?
|
| Catalytic Domain | 1 | 2002 | 699 | 0.040 |
Why?
|
| Transcriptional Activation | 2 | 2018 | 1750 | 0.040 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2004 | 977 | 0.040 |
Why?
|
| Neural Cell Adhesion Molecule L1 | 1 | 1999 | 44 | 0.040 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2014 | 5342 | 0.040 |
Why?
|
| Xenopus laevis | 1 | 2003 | 966 | 0.040 |
Why?
|
| Neural Cell Adhesion Molecules | 1 | 1999 | 122 | 0.040 |
Why?
|
| Tetradecanoylphorbol Acetate | 2 | 1998 | 826 | 0.040 |
Why?
|
| Doxycycline | 1 | 2001 | 349 | 0.040 |
Why?
|
| Coronary Disease | 1 | 2013 | 5919 | 0.040 |
Why?
|
| Phosphoenolpyruvate Carboxykinase (ATP) | 1 | 1998 | 14 | 0.040 |
Why?
|
| Intracellular Membranes | 1 | 1999 | 388 | 0.040 |
Why?
|
| Thermosensing | 1 | 2018 | 56 | 0.040 |
Why?
|
| Homozygote | 1 | 2003 | 1779 | 0.040 |
Why?
|
| Solid Phase Extraction | 1 | 2018 | 28 | 0.040 |
Why?
|
| Health Status Indicators | 1 | 2003 | 971 | 0.040 |
Why?
|
| Diabetes, Gestational | 1 | 2008 | 1260 | 0.040 |
Why?
|
| Heterosexuality | 1 | 2000 | 309 | 0.040 |
Why?
|
| Hydrolysis | 1 | 2019 | 646 | 0.040 |
Why?
|
| Neuropeptides | 1 | 2004 | 951 | 0.040 |
Why?
|
| Genes, Reporter | 2 | 2004 | 1524 | 0.040 |
Why?
|
| Alcohol Oxidoreductases | 1 | 1998 | 164 | 0.040 |
Why?
|
| Oxygen Consumption | 2 | 2018 | 1883 | 0.040 |
Why?
|
| Receptor, IGF Type 1 | 3 | 2008 | 384 | 0.040 |
Why?
|
| Antigens, CD | 1 | 2008 | 4032 | 0.040 |
Why?
|
| Glucose Transporter Type 5 | 1 | 2017 | 13 | 0.040 |
Why?
|
| Fibrosis | 1 | 2024 | 2081 | 0.040 |
Why?
|
| Adipocytes, Brown | 1 | 2018 | 160 | 0.040 |
Why?
|
| Okadaic Acid | 1 | 1997 | 67 | 0.040 |
Why?
|
| Glucose Transporter Type 2 | 1 | 2017 | 61 | 0.040 |
Why?
|
| 1-Methyl-3-isobutylxanthine | 1 | 1997 | 100 | 0.040 |
Why?
|
| Hip Dislocation | 1 | 2000 | 249 | 0.040 |
Why?
|
| Survivors | 4 | 2003 | 2383 | 0.040 |
Why?
|
| Muscle Contraction | 2 | 2000 | 1209 | 0.040 |
Why?
|
| Glucose Transport Proteins, Facilitative | 1 | 2017 | 57 | 0.030 |
Why?
|
| Rats, Wistar | 2 | 2002 | 1890 | 0.030 |
Why?
|
| Quality of Life | 4 | 2003 | 13510 | 0.030 |
Why?
|
| Gene Transfer Techniques | 2 | 2005 | 1209 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2000 | 10778 | 0.030 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 2016 | 1683 | 0.030 |
Why?
|
| Indinavir | 1 | 2016 | 73 | 0.030 |
Why?
|
| Life Style | 2 | 2007 | 3931 | 0.030 |
Why?
|
| Insulin-Like Growth Factor I | 2 | 2003 | 1942 | 0.030 |
Why?
|
| Aging | 5 | 2003 | 8765 | 0.030 |
Why?
|
| Human Growth Hormone | 1 | 2021 | 648 | 0.030 |
Why?
|
| Bone Morphogenetic Protein 4 | 1 | 2017 | 163 | 0.030 |
Why?
|
| Tritium | 1 | 2017 | 707 | 0.030 |
Why?
|
| Hemostasis | 1 | 1999 | 468 | 0.030 |
Why?
|
| CHO Cells | 3 | 2011 | 1380 | 0.030 |
Why?
|
| Infusions, Intravenous | 2 | 2003 | 2231 | 0.030 |
Why?
|
| Regression Analysis | 2 | 2018 | 6346 | 0.030 |
Why?
|
| Methionine | 1 | 1999 | 573 | 0.030 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2005 | 2911 | 0.030 |
Why?
|
| Immunoprecipitation | 2 | 2012 | 874 | 0.030 |
Why?
|
| Antibodies | 3 | 1995 | 2422 | 0.030 |
Why?
|
| Organ Size | 2 | 1999 | 2268 | 0.030 |
Why?
|
| Paraventricular Hypothalamic Nucleus | 1 | 2016 | 121 | 0.030 |
Why?
|
| Autocrine Communication | 1 | 2017 | 168 | 0.030 |
Why?
|
| Guanosine Triphosphate | 1 | 1997 | 315 | 0.030 |
Why?
|
| Antigens, Differentiation | 1 | 1999 | 921 | 0.030 |
Why?
|
| Substrate Specificity | 2 | 2016 | 1751 | 0.030 |
Why?
|
| Protein Kinase C-delta | 1 | 1996 | 115 | 0.030 |
Why?
|
| Animals, Genetically Modified | 1 | 2001 | 1564 | 0.030 |
Why?
|
| Animal Nutritional Physiological Phenomena | 1 | 1995 | 54 | 0.030 |
Why?
|
| Carbohydrates | 1 | 2018 | 389 | 0.030 |
Why?
|
| Amino Acid Substitution | 1 | 2000 | 1741 | 0.030 |
Why?
|
| Lipoprotein Lipase | 1 | 1996 | 133 | 0.030 |
Why?
|
| Weight Loss | 2 | 2007 | 2720 | 0.030 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 1 | 1998 | 480 | 0.030 |
Why?
|
| Neuropeptide Y | 1 | 2016 | 194 | 0.030 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 2 | 2010 | 615 | 0.030 |
Why?
|
| MAP Kinase Signaling System | 1 | 2002 | 1494 | 0.030 |
Why?
|
| Immunoglobulin G | 1 | 1987 | 4568 | 0.030 |
Why?
|
| Phenotype | 4 | 2011 | 16735 | 0.030 |
Why?
|
| Receptors, Adrenergic, beta | 1 | 1995 | 243 | 0.030 |
Why?
|
| Longevity | 1 | 2003 | 1077 | 0.030 |
Why?
|
| Microscopy, Electron | 1 | 2018 | 2560 | 0.030 |
Why?
|
| Intraoperative Complications | 1 | 2002 | 1176 | 0.030 |
Why?
|
| Lipase | 1 | 2017 | 321 | 0.030 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2005 | 2813 | 0.030 |
Why?
|
| Epididymis | 2 | 1993 | 227 | 0.030 |
Why?
|
| Ribosomes | 1 | 1998 | 499 | 0.030 |
Why?
|
| Carbohydrate Metabolism | 1 | 1995 | 262 | 0.030 |
Why?
|
| Oligonucleotide Probes | 1 | 1995 | 417 | 0.030 |
Why?
|
| Integrins | 1 | 1999 | 843 | 0.030 |
Why?
|
| Dendritic Spines | 1 | 2016 | 244 | 0.030 |
Why?
|
| Mycobacterium | 1 | 2016 | 252 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 4 | 1999 | 6131 | 0.030 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2011 | 5707 | 0.030 |
Why?
|
| Food Deprivation | 1 | 1994 | 114 | 0.030 |
Why?
|
| Epidemiologic Studies | 1 | 1998 | 677 | 0.030 |
Why?
|
| Cloning, Molecular | 2 | 2016 | 4168 | 0.030 |
Why?
|
| Recurrence | 1 | 2006 | 8512 | 0.030 |
Why?
|
| Metformin | 1 | 2002 | 909 | 0.030 |
Why?
|
| Receptors, Drug | 1 | 1994 | 157 | 0.030 |
Why?
|
| Muscular Diseases | 1 | 2018 | 555 | 0.030 |
Why?
|
| Epidermal Growth Factor | 1 | 1997 | 697 | 0.030 |
Why?
|
| Peptides | 4 | 1995 | 4353 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 2016 | 583 | 0.030 |
Why?
|
| Vagina | 1 | 1999 | 848 | 0.030 |
Why?
|
| Fat Emulsions, Intravenous | 1 | 1996 | 314 | 0.030 |
Why?
|
| Pelvic Bones | 1 | 2016 | 274 | 0.030 |
Why?
|
| Molecular Probes | 1 | 1995 | 309 | 0.030 |
Why?
|
| Arthroplasty | 1 | 2016 | 310 | 0.030 |
Why?
|
| Physical Examination | 1 | 1999 | 1262 | 0.030 |
Why?
|
| Potassium Channels, Inwardly Rectifying | 1 | 1994 | 144 | 0.030 |
Why?
|
| Body Temperature Regulation | 1 | 2015 | 292 | 0.030 |
Why?
|
| Epinephrine | 1 | 2016 | 794 | 0.030 |
Why?
|
| Genes | 3 | 1993 | 1824 | 0.030 |
Why?
|
| Knee Prosthesis | 1 | 2016 | 395 | 0.030 |
Why?
|
| Affinity Labels | 1 | 1992 | 107 | 0.030 |
Why?
|
| Estrogen Replacement Therapy | 1 | 1999 | 1209 | 0.030 |
Why?
|
| Clathrin-Coated Vesicles | 1 | 2013 | 67 | 0.030 |
Why?
|
| Cell Count | 1 | 2017 | 1833 | 0.030 |
Why?
|
| Receptors, Immunologic | 1 | 1999 | 1418 | 0.030 |
Why?
|
| Creatine Kinase | 2 | 2007 | 685 | 0.030 |
Why?
|
| Membranes | 1 | 1992 | 164 | 0.030 |
Why?
|
| Caloric Restriction | 2 | 2007 | 301 | 0.030 |
Why?
|
| Breast Neoplasms | 4 | 2003 | 21187 | 0.030 |
Why?
|
| Prediabetic State | 2 | 2013 | 548 | 0.030 |
Why?
|
| Consensus Development Conferences, NIH as Topic | 1 | 2012 | 29 | 0.030 |
Why?
|
| Gene Silencing | 1 | 2018 | 1505 | 0.020 |
Why?
|
| Menopause | 1 | 2000 | 1656 | 0.020 |
Why?
|
| Glyceraldehyde-3-Phosphate Dehydrogenases | 1 | 1992 | 79 | 0.020 |
Why?
|
| Microtubules | 1 | 1998 | 1062 | 0.020 |
Why?
|
| Infusions, Intraventricular | 1 | 2011 | 31 | 0.020 |
Why?
|
| Time-Lapse Imaging | 1 | 2013 | 194 | 0.020 |
Why?
|
| Macrophages, Peritoneal | 1 | 2013 | 244 | 0.020 |
Why?
|
| Housing, Animal | 1 | 2011 | 47 | 0.020 |
Why?
|
| Haplorhini | 1 | 1992 | 524 | 0.020 |
Why?
|
| Glucosephosphates | 1 | 1991 | 19 | 0.020 |
Why?
|
| Hyperlipidemias | 1 | 1996 | 773 | 0.020 |
Why?
|
| Chromatography, Affinity | 1 | 1992 | 525 | 0.020 |
Why?
|
| Point Mutation | 1 | 1997 | 1595 | 0.020 |
Why?
|
| Rodentia | 1 | 1992 | 262 | 0.020 |
Why?
|
| Workflow | 1 | 2016 | 859 | 0.020 |
Why?
|
| Arthroplasty, Replacement, Knee | 1 | 2002 | 1405 | 0.020 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 1999 | 1751 | 0.020 |
Why?
|
| Adaptation, Physiological | 1 | 1998 | 1315 | 0.020 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 1994 | 647 | 0.020 |
Why?
|
| Exercise Therapy | 1 | 1998 | 938 | 0.020 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 1994 | 567 | 0.020 |
Why?
|
| Tissue Culture Techniques | 1 | 2011 | 290 | 0.020 |
Why?
|
| Postmenopause | 1 | 1999 | 2519 | 0.020 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 6 | 2 | 2001 | 121 | 0.020 |
Why?
|
| Acromegaly | 1 | 1993 | 316 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 2 | 1991 | 2475 | 0.020 |
Why?
|
| Rabbits | 2 | 1995 | 4774 | 0.020 |
Why?
|
| Deoxycytidine | 1 | 1994 | 888 | 0.020 |
Why?
|
| Hip Prosthesis | 1 | 2016 | 924 | 0.020 |
Why?
|
| Pancreas | 2 | 2008 | 1700 | 0.020 |
Why?
|
| Conserved Sequence | 1 | 2013 | 1162 | 0.020 |
Why?
|
| Diet, Atherogenic | 1 | 2009 | 92 | 0.020 |
Why?
|
| Albuminuria | 1 | 2013 | 658 | 0.020 |
Why?
|
| Erythroid Precursor Cells | 1 | 1990 | 212 | 0.020 |
Why?
|
| Cell Separation | 1 | 1995 | 1728 | 0.020 |
Why?
|
| DNA Probes | 1 | 1990 | 543 | 0.020 |
Why?
|
| Duodenum | 1 | 1992 | 495 | 0.020 |
Why?
|
| Alleles | 1 | 2020 | 6901 | 0.020 |
Why?
|
| Dexamethasone | 1 | 1997 | 1965 | 0.020 |
Why?
|
| Immediate-Early Proteins | 1 | 1992 | 444 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2008 | 4593 | 0.020 |
Why?
|
| Multigene Family | 1 | 1992 | 1082 | 0.020 |
Why?
|
| Adolescent | 5 | 2009 | 89247 | 0.020 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2004 | 3780 | 0.020 |
Why?
|
| Endocytosis | 1 | 2013 | 959 | 0.020 |
Why?
|
| Antibodies, Neutralizing | 1 | 2018 | 2009 | 0.020 |
Why?
|
| Tamoxifen | 1 | 2013 | 967 | 0.020 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2012 | 794 | 0.020 |
Why?
|
| Protein Biosynthesis | 1 | 1995 | 2094 | 0.020 |
Why?
|
| Thyrotropin-Releasing Hormone | 1 | 1988 | 139 | 0.020 |
Why?
|
| Membrane Glycoproteins | 1 | 1999 | 3714 | 0.020 |
Why?
|
| Ictaluridae | 1 | 1987 | 8 | 0.020 |
Why?
|
| Epithelium | 1 | 1992 | 1607 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2007 | 16051 | 0.020 |
Why?
|
| Aspartic Acid | 2 | 2000 | 577 | 0.020 |
Why?
|
| Radioligand Assay | 1 | 1988 | 367 | 0.020 |
Why?
|
| Islets of Langerhans Transplantation | 1 | 1993 | 748 | 0.020 |
Why?
|
| Farnesyltranstransferase | 2 | 1999 | 71 | 0.020 |
Why?
|
| Cathepsin L | 1 | 2007 | 69 | 0.020 |
Why?
|
| Exons | 1 | 1993 | 2395 | 0.020 |
Why?
|
| Oocytes | 1 | 1992 | 1172 | 0.020 |
Why?
|
| Longitudinal Studies | 3 | 2008 | 14795 | 0.020 |
Why?
|
| Adaptation, Psychological | 2 | 1996 | 2667 | 0.020 |
Why?
|
| Nucleotidases | 1 | 1987 | 29 | 0.020 |
Why?
|
| Peptide Fragments | 1 | 2000 | 5150 | 0.020 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2010 | 859 | 0.020 |
Why?
|
| NADH Dehydrogenase | 1 | 1987 | 47 | 0.020 |
Why?
|
| Knee Joint | 1 | 2016 | 1685 | 0.020 |
Why?
|
| Goats | 1 | 1987 | 166 | 0.020 |
Why?
|
| Epoxy Compounds | 1 | 2007 | 137 | 0.020 |
Why?
|
| Sulfonamides | 1 | 1997 | 1982 | 0.020 |
Why?
|
| CCAAT-Enhancer-Binding Protein-alpha | 1 | 2007 | 130 | 0.020 |
Why?
|
| Heart | 2 | 1998 | 4448 | 0.020 |
Why?
|
| Enhancer Elements, Genetic | 1 | 1993 | 1369 | 0.020 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2013 | 1197 | 0.020 |
Why?
|
| Doxorubicin | 1 | 2013 | 2234 | 0.020 |
Why?
|
| Follow-Up Studies | 5 | 2013 | 39394 | 0.020 |
Why?
|
| Lipocalins | 1 | 2007 | 161 | 0.020 |
Why?
|
| Horses | 1 | 1987 | 296 | 0.020 |
Why?
|
| Adenosine Triphosphate | 2 | 2008 | 2003 | 0.020 |
Why?
|
| Diabetic Nephropathies | 1 | 2013 | 973 | 0.020 |
Why?
|
| Retrospective Studies | 2 | 2021 | 81892 | 0.020 |
Why?
|
| Phosphorus | 1 | 1987 | 336 | 0.020 |
Why?
|
| Models, Animal | 2 | 2004 | 2123 | 0.020 |
Why?
|
| Mesenchymal Stem Cells | 1 | 2017 | 1672 | 0.020 |
Why?
|
| Sjogren's Syndrome | 1 | 1988 | 241 | 0.020 |
Why?
|
| Motor Activity | 2 | 2007 | 2722 | 0.020 |
Why?
|
| RNA, Small Interfering | 2 | 2005 | 3433 | 0.020 |
Why?
|
| 5'-Nucleotidase | 1 | 1987 | 164 | 0.020 |
Why?
|
| Lipopolysaccharides | 1 | 2013 | 2222 | 0.020 |
Why?
|
| Environment | 1 | 2011 | 1125 | 0.020 |
Why?
|
| Sex Characteristics | 1 | 1996 | 2660 | 0.020 |
Why?
|
| Postoperative Complications | 3 | 2005 | 15889 | 0.020 |
Why?
|
| Antibodies, Phospho-Specific | 1 | 2005 | 15 | 0.020 |
Why?
|
| Galactosyltransferases | 1 | 1987 | 284 | 0.020 |
Why?
|
| Drug Discovery | 1 | 2013 | 1068 | 0.020 |
Why?
|
| Germany | 1 | 2007 | 883 | 0.020 |
Why?
|
| Fibroblasts | 3 | 2005 | 4178 | 0.020 |
Why?
|
| Immunoenzyme Techniques | 1 | 2008 | 1705 | 0.020 |
Why?
|
| Cystic Fibrosis | 1 | 1994 | 1295 | 0.010 |
Why?
|
| Lac Operon | 1 | 2005 | 237 | 0.010 |
Why?
|
| Health Services Needs and Demand | 1 | 1992 | 1407 | 0.010 |
Why?
|
| Stearoyl-CoA Desaturase | 1 | 2005 | 84 | 0.010 |
Why?
|
| Protein Binding | 1 | 1996 | 9344 | 0.010 |
Why?
|
| Alanine Transaminase | 1 | 2007 | 606 | 0.010 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2009 | 1339 | 0.010 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2007 | 507 | 0.010 |
Why?
|
| Milk Proteins | 1 | 2004 | 161 | 0.010 |
Why?
|
| Muscle Cells | 1 | 2005 | 195 | 0.010 |
Why?
|
| STAT5 Transcription Factor | 1 | 2004 | 268 | 0.010 |
Why?
|
| Gene Amplification | 1 | 2008 | 1099 | 0.010 |
Why?
|
| Fibronectins | 1 | 2007 | 724 | 0.010 |
Why?
|
| rho-Associated Kinases | 1 | 2005 | 285 | 0.010 |
Why?
|
| Mutation | 2 | 2005 | 30266 | 0.010 |
Why?
|
| Placenta | 1 | 1992 | 1721 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 2 | 2007 | 6085 | 0.010 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2004 | 690 | 0.010 |
Why?
|
| Pregnancy | 3 | 2008 | 30175 | 0.010 |
Why?
|
| Body Constitution | 1 | 2003 | 273 | 0.010 |
Why?
|
| Linkage Disequilibrium | 1 | 2007 | 1998 | 0.010 |
Why?
|
| Osteolysis | 1 | 2004 | 274 | 0.010 |
Why?
|
| Sirolimus | 2 | 2000 | 1540 | 0.010 |
Why?
|
| Lactation | 1 | 2004 | 392 | 0.010 |
Why?
|
| Sterol Regulatory Element Binding Protein 1 | 1 | 2002 | 136 | 0.010 |
Why?
|
| Rats, Inbred BN | 1 | 2001 | 231 | 0.010 |
Why?
|
| Stromal Cells | 1 | 2007 | 1337 | 0.010 |
Why?
|
| Depression, Chemical | 1 | 2001 | 186 | 0.010 |
Why?
|
| Creatine Kinase, MM Form | 1 | 2001 | 10 | 0.010 |
Why?
|
| Molecular Targeted Therapy | 1 | 2013 | 2830 | 0.010 |
Why?
|
| NF-kappa B | 1 | 2010 | 2492 | 0.010 |
Why?
|
| Diaphragm | 1 | 2003 | 357 | 0.010 |
Why?
|
| Protein-Tyrosine Kinases | 2 | 2002 | 2433 | 0.010 |
Why?
|
| Thymidine | 1 | 2001 | 297 | 0.010 |
Why?
|
| Immunohistochemistry | 2 | 2005 | 11119 | 0.010 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 1 | 2002 | 288 | 0.010 |
Why?
|
| Risk Factors | 3 | 2013 | 74971 | 0.010 |
Why?
|
| Sex Counseling | 1 | 2000 | 18 | 0.010 |
Why?
|
| Amino Acids | 1 | 2007 | 1716 | 0.010 |
Why?
|
| Temperature | 1 | 1987 | 2235 | 0.010 |
Why?
|
| Blood Loss, Surgical | 1 | 2005 | 643 | 0.010 |
Why?
|
| Erythrocytes | 1 | 1990 | 2421 | 0.010 |
Why?
|
| Sodium-Phosphate Cotransporter Proteins | 1 | 2000 | 7 | 0.010 |
Why?
|
| Rats, Inbred F344 | 1 | 2001 | 825 | 0.010 |
Why?
|
| Diagnostic Errors | 1 | 1988 | 1281 | 0.010 |
Why?
|
| Arteriosclerosis | 1 | 2005 | 1056 | 0.010 |
Why?
|
| Sexual Behavior | 2 | 2003 | 2200 | 0.010 |
Why?
|
| Thyroid Hormones | 1 | 2003 | 407 | 0.010 |
Why?
|
| Amenorrhea | 1 | 2003 | 484 | 0.010 |
Why?
|
| Nutritional Status | 1 | 1988 | 1627 | 0.010 |
Why?
|
| Insulin Infusion Systems | 1 | 2001 | 221 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2013 | 12093 | 0.010 |
Why?
|
| Sex Factors | 1 | 1993 | 10641 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2001 | 474 | 0.010 |
Why?
|
| Length of Stay | 2 | 2005 | 6525 | 0.010 |
Why?
|
| Demography | 2 | 1996 | 1643 | 0.010 |
Why?
|
| Kidney Tubules | 1 | 2001 | 454 | 0.010 |
Why?
|
| RNA-Binding Proteins | 1 | 2008 | 1891 | 0.010 |
Why?
|
| Reproduction | 1 | 2003 | 646 | 0.010 |
Why?
|
| Liver Neoplasms, Experimental | 1 | 2000 | 189 | 0.010 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2005 | 1120 | 0.010 |
Why?
|
| Pyruvic Acid | 1 | 2000 | 205 | 0.010 |
Why?
|
| Focal Adhesion Kinase 1 | 1 | 1999 | 120 | 0.010 |
Why?
|
| Eukaryotic Initiation Factors | 1 | 1999 | 83 | 0.010 |
Why?
|
| Janus Kinase 2 | 1 | 2002 | 560 | 0.010 |
Why?
|
| Focal Adhesion Protein-Tyrosine Kinases | 1 | 1999 | 185 | 0.010 |
Why?
|
| Comorbidity | 1 | 2013 | 10591 | 0.010 |
Why?
|
| Sickness Impact Profile | 1 | 1999 | 299 | 0.010 |
Why?
|
| Chloramphenicol O-Acetyltransferase | 1 | 1998 | 221 | 0.010 |
Why?
|
| Ouabain | 1 | 1998 | 246 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2004 | 1408 | 0.010 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 1992 | 2445 | 0.010 |
Why?
|
| Mammals | 1 | 2003 | 1136 | 0.010 |
Why?
|
| Luminescent Proteins | 1 | 2000 | 839 | 0.010 |
Why?
|
| Calmodulin | 1 | 1998 | 241 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 2016 | 7472 | 0.010 |
Why?
|
| Research Design | 1 | 2013 | 6213 | 0.010 |
Why?
|
| Prosthesis Design | 1 | 2004 | 2126 | 0.010 |
Why?
|
| Anesthesia, Conduction | 1 | 2000 | 263 | 0.010 |
Why?
|
| Alcoholism | 1 | 1988 | 1981 | 0.010 |
Why?
|
| Interleukin-6 | 1 | 2007 | 3233 | 0.010 |
Why?
|
| Catalysis | 1 | 1998 | 768 | 0.010 |
Why?
|
| Polymorphism, Genetic | 2 | 2000 | 4251 | 0.010 |
Why?
|
| Vaginal Smears | 1 | 1999 | 505 | 0.010 |
Why?
|
| Arginine | 1 | 2000 | 932 | 0.010 |
Why?
|
| src-Family Kinases | 1 | 1999 | 539 | 0.010 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2000 | 682 | 0.010 |
Why?
|
| Binding Sites | 1 | 2005 | 6023 | 0.010 |
Why?
|
| Transferases | 1 | 1996 | 71 | 0.010 |
Why?
|
| RNA Interference | 1 | 2005 | 2835 | 0.010 |
Why?
|
| Hexoses | 1 | 1995 | 29 | 0.010 |
Why?
|
| Receptors, Adrenergic, beta-1 | 1 | 1995 | 52 | 0.010 |
Why?
|
| Prevalence | 1 | 2013 | 15875 | 0.010 |
Why?
|
| Receptors, Adrenergic, beta-3 | 1 | 1995 | 63 | 0.010 |
Why?
|
| Chromones | 1 | 1996 | 148 | 0.010 |
Why?
|
| Chi-Square Distribution | 1 | 2002 | 3438 | 0.010 |
Why?
|
| Pyridines | 1 | 2007 | 2896 | 0.010 |
Why?
|
| Positron-Emission Tomography | 1 | 2012 | 6673 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2013 | 22294 | 0.010 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2003 | 3554 | 0.010 |
Why?
|
| C-Reactive Protein | 1 | 2007 | 3858 | 0.010 |
Why?
|
| Flavonoids | 1 | 1998 | 447 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 1998 | 1990 | 0.010 |
Why?
|
| Prospective Studies | 2 | 2013 | 54950 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2011 | 17174 | 0.010 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 1999 | 2488 | 0.010 |
Why?
|
| Receptors, Adrenergic, beta-2 | 1 | 1995 | 216 | 0.010 |
Why?
|
| Green Fluorescent Proteins | 1 | 2000 | 2067 | 0.010 |
Why?
|
| Behavior Therapy | 1 | 2000 | 886 | 0.010 |
Why?
|
| Keratinocytes | 1 | 1999 | 876 | 0.010 |
Why?
|
| Atrophy | 1 | 1999 | 1647 | 0.010 |
Why?
|
| Aged, 80 and over | 3 | 2005 | 59738 | 0.010 |
Why?
|
| Age of Onset | 1 | 2001 | 3346 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 1998 | 2749 | 0.010 |
Why?
|
| Treatment Outcome | 3 | 2008 | 65485 | 0.010 |
Why?
|
| Glyburide | 1 | 1994 | 117 | 0.010 |
Why?
|
| Calcium | 2 | 1998 | 5792 | 0.010 |
Why?
|
| Somatomedins | 1 | 1993 | 179 | 0.010 |
Why?
|
| Cell Adhesion Molecules | 1 | 1999 | 1614 | 0.010 |
Why?
|
| Morpholines | 1 | 1996 | 584 | 0.010 |
Why?
|
| Epithelial Cells | 1 | 2004 | 3701 | 0.010 |
Why?
|
| Hyperglycemia | 1 | 2001 | 1389 | 0.010 |
Why?
|
| Osmolar Concentration | 1 | 1993 | 657 | 0.010 |
Why?
|
| Hybrid Cells | 1 | 1992 | 421 | 0.010 |
Why?
|
| Molecular Conformation | 1 | 1993 | 540 | 0.010 |
Why?
|
| Early Growth Response Protein 1 | 1 | 1992 | 133 | 0.010 |
Why?
|
| Pancreas Transplantation | 1 | 1993 | 193 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2007 | 9384 | 0.010 |
Why?
|
| Data Interpretation, Statistical | 1 | 2002 | 2714 | 0.010 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2003 | 3613 | 0.010 |
Why?
|
| Immune Sera | 1 | 1992 | 605 | 0.010 |
Why?
|
| Weight Gain | 1 | 2002 | 2359 | 0.010 |
Why?
|
| Tomography, Emission-Computed | 1 | 1994 | 1126 | 0.010 |
Why?
|
| Biopsy | 2 | 1993 | 6805 | 0.010 |
Why?
|
| Hepatic Veins | 1 | 1991 | 112 | 0.010 |
Why?
|
| Radioisotope Dilution Technique | 1 | 1990 | 71 | 0.010 |
Why?
|
| Cell Nucleus | 1 | 2000 | 2885 | 0.010 |
Why?
|
| Smoking | 1 | 1988 | 9094 | 0.010 |
Why?
|
| Mutation, Missense | 1 | 2000 | 2592 | 0.010 |
Why?
|
| Electron Transport Complex IV | 1 | 1990 | 192 | 0.010 |
Why?
|
| Patient Education as Topic | 1 | 2000 | 2339 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 1999 | 6232 | 0.010 |
Why?
|
| Molecular Weight | 1 | 1992 | 2173 | 0.010 |
Why?
|
| Potassium | 1 | 1994 | 1319 | 0.010 |
Why?
|
| Carbon Radioisotopes | 1 | 1990 | 567 | 0.010 |
Why?
|
| Radiography | 1 | 2000 | 6991 | 0.010 |
Why?
|
| Skin | 1 | 2003 | 4507 | 0.010 |
Why?
|
| Decision Support Techniques | 1 | 1999 | 2008 | 0.010 |
Why?
|
| Hippocampus | 1 | 2002 | 3786 | 0.010 |
Why?
|
| Alkaline Phosphatase | 1 | 1992 | 864 | 0.000 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 1992 | 792 | 0.000 |
Why?
|
| Gene Expression Profiling | 1 | 2004 | 9549 | 0.000 |
Why?
|
| Cell Cycle Proteins | 1 | 1999 | 3450 | 0.000 |
Why?
|
| Renin-Angiotensin System | 1 | 1992 | 736 | 0.000 |
Why?
|
| Risk | 1 | 1999 | 9621 | 0.000 |
Why?
|
| Cardiovascular Diseases | 1 | 2013 | 15662 | 0.000 |
Why?
|
| Syndrome | 1 | 1993 | 3274 | 0.000 |
Why?
|
| HIV Infections | 1 | 1992 | 17589 | 0.000 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 1994 | 2056 | 0.000 |
Why?
|
| Social Support | 1 | 1996 | 2193 | 0.000 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2007 | 18065 | 0.000 |
Why?
|
| Administration, Oral | 1 | 1993 | 4042 | 0.000 |
Why?
|
| Affect | 1 | 1992 | 1500 | 0.000 |
Why?
|
| Mass Screening | 1 | 2000 | 5455 | 0.000 |
Why?
|
| Sensitivity and Specificity | 1 | 1999 | 14751 | 0.000 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 1992 | 2203 | 0.000 |
Why?
|
| Neuroblastoma | 1 | 1992 | 1266 | 0.000 |
Why?
|
| United States | 1 | 2012 | 73180 | 0.000 |
Why?
|
| RNA | 1 | 1993 | 2727 | 0.000 |
Why?
|
| Activities of Daily Living | 1 | 1992 | 2433 | 0.000 |
Why?
|
| Patient Satisfaction | 1 | 1996 | 3489 | 0.000 |
Why?
|
| Psychometrics | 1 | 1992 | 3066 | 0.000 |
Why?
|
| Young Adult | 1 | 2009 | 60110 | 0.000 |
Why?
|
| Child | 1 | 2009 | 80969 | 0.000 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2007 | 36861 | 0.000 |
Why?
|
| Kidney Transplantation | 1 | 1993 | 4265 | 0.000 |
Why?
|
| Adenocarcinoma | 1 | 1994 | 6401 | 0.000 |
Why?
|
| Glioma | 1 | 1992 | 3532 | 0.000 |
Why?
|